Skip to main content
. 2022 Nov 2;6(3):e1741. doi: 10.1002/cnr2.1741

FIGURE 5.

FIGURE 5

Prognosis evaluation of different BC clinical pathological feature subgroups based on ARG signature; (A) age > 60; (B) age ≤ 60; (C) M0; (D) N0; (E) N1‐3; (F) Stage I–II; (G) Stage III–IV; (H) T1‐2; and (I)T3‐4. ARG, aging‐related gene; BC, breast cancer